Biotechnology
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset
* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...
2019-12-02 18:28
2524
CMAB Biopharma and Fapon Biopharma Sign Agreement to Develop and Manufacture a Biologic Oncology Asset
* The newly founded relationship will combine the research and development ingenuity of Fapon Biopharma with the state-of-art biologics manufacturing services offered by CMAB * CMAB will provide a full range of development and manufacturing services for Fapon Biopharma's biologic drug project...
2019-12-02 18:18
1318
Tyvyt (Sintilimab Injection), an Innovative PD-1 Inhibitor Jointly Developed by Innovent and Lilly, is Included in the New Catalogue of National Reimbursement Drug List (NRDL)
SUZHOU, China, Nov. 28, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today jointly announced...
2019-11-28 12:10
4416
VUNO Presents the Future of Medical AI Solutions at RSNA 2019
CHICAGO, Nov. 27, 2019 /PRNewswire/ -- VUNO Inc., a medical AI solution
developer and a member company of the Born2Global Centre, will participate in
RSNA (Radiological Society ofNorth America) 2019 in Chicago, December
1-8. Booth: North Hall Level2, #11132.
2019-11-27 21:30
1729
Golden Meditech Announces FY2019/2020 Interim Results
Revenue Fluctuated Amidst the Challenging Market Conditions Significant Increase in Revenue Noted at Beijing Sunbow Obstetrics & Gynecology Hospital HONG KONG, Nov. 27, 2019 /PRNewswire/ -- For the Six Months Ended 30 September 2019 (HK$'000) 2018 (HK$'000) Change (%) Revenue 157,2...
2019-11-27 18:52
5088
Global Cord Blood Corporation Reports Financial Results for the Second Quarter and First Half of Fiscal 2020
HONG KONG, Nov. 27, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced its unaudited financial results for...
2019-11-27 05:16
11234
New Study by TauRx Shows a Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer's Disease
ABERDEEN, Scotland and SINGAPORE, Nov. 27, 2019 /PRNewswire/ -- In a paper published in today's online issue of theJournal of Alzheimer's Disease (DOI 10.3233/JAD-190772), TauRx has reported unexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels ...
2019-11-27 02:31
1650
Japan and Singapore Grant CRISPR Patents to Merck
- Merck now holds 22 CRISPR-related patents worldwide across nine different geographies - Patents cover Paired Cas9 Nickase CRISPR genome-editing technology to advance gene therapy and research DARMSTADT, Germany, Nov. 26, 2019 /PRNewswire/ -- Merck, a leading science and technology company, to...
2019-11-26 21:00
2083
Novoheart to Co-develop First of its Kind Human Heart-in-a-Jar Model of Heart Failure with AstraZeneca
* Heart failure is a global pandemic with an estimated 64.3 million cases worldwide in 2017, costing overUS$100B per year * Drug developers currently lack effective humanized models for preclinical testing of targeted drug candidates in heart failure with preserved ejection fraction * The c...
2019-11-26 16:31
2418
USD 10 million transaction generated at Asia Agri-Tech Expo & Forum 2019 concluded on 2 November
TAIPEI, Nov. 25, 2019 /PRNewswire/ -- Taiwan premier agricultural international exhibition, Asia Agri-Tech Expo & Forum 2019, has concluded in November at Taipei Nangang Exhibition Center, Hall 1. Co-located with Aquaculture Taiwan and Livestock Taiwan, the triple show attracted more than 25,000 ...
2019-11-25 15:58
3634
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland
DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...
2019-11-23 01:55
5345
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...
2019-11-21 20:00
5910
Ascentage Pharma Breaks Ground on its Global Headquarters, R&D Center and Manufacturing Facility in the Suzhou Industrial Park
SUZHOU, China and ROCKVILLE, Md., Nov. 20, 2019 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies, announced that the groundbreaking ceremony for the Company's global headquarters, R&D center, and manufacturi...
2019-11-21 11:30
1672
Global Cord Blood Corp Comments on New Regulation
HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...
2019-11-20 20:00
5562
Two Prominent Researchers of WPI-MANA and University of Washington Discuss Development of Smart Polymers and Biomaterials
TSUKUBA, Japan, Nov. 20, 2019 /PRNewswire/ -- The International Center for Materials Nanoarchitectonics (WPI-MANA), a unit of the National Institute for Materials Science (NIMS), had a visit from Prof.Allan S. Hoffman from the University of Washington, a pioneer in smart polymers and biomaterials...
2019-11-20 14:00
930
ABL Bio Inc.- GenScript Biotech Corp Bispecific Antibody Strategic Partnership Agreement Ceremony
NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL Bio Inc., a South Korean biotech company dedicated to therapeutics for immuno-oncology and neurodeg...
2019-11-18 22:00
1595
RhoVac Reports Interim Results on Immunological Response with RV001
STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen,Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In July 2019 RhoVac publishe...
2019-11-18 17:13
1070
Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People
BANGKOK, Nov. 17, 2019 /PRNewswire/ -- In anticipation of World Antibiotic Awareness Week (18-24 November) the Antimicrobial Resistance (AMR) Summit Expert Group and the Antimicrobial Stewardship (AMS) Working Group convened in Bangkok, Thailand, in a first-ever regional effort to combat the 'sile...
2019-11-17 12:00
2278
Viva Biotech Partnership Summit Successfully Launched in Shanghai
SHANGHAI, Nov. 15, 2019 /PRNewswire/ -- 2019 Viva Biotech Partnership Summit (the "Summit") was successfully launched on8 November 2019 in Pudong, Shanghai, themed "Innovation Partnership Growth". Founders from over 30 global innovative and biopharmaceutical companies incubated/ invested by Viva ...
2019-11-15 14:16
2279
World's First Candidate Antibody Treatment for Yellow Fever, Developed by Tychan, Tested Safe and Effective in Human Volunteers
* Phase 1A/1B safety and efficacy trials in Singapore completed within 8 months * TY014 also found to prevent vaccine related adverse effects in vaccinated volunteers SINGAPORE, Nov. 14, 2019 /PRNewswire/ -- Tychan's first-in-class monoclonal antibody candidate treatment for Yellow Fever (YF)...
2019-11-14 11:07
1327
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6933
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
6853
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6316
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
5639
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5543
